The cost of Lantus pens can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. Lantus is a brand-name insulin glargine injection used to treat high blood sugar in adults and children with diabetes.
How Much Do Lantus Pens Typically Cost?
Without insurance, a box of five Lantus SoloSTAR pens (each containing 3 mL of insulin) can range from approximately $300 to over $400. Prices may fluctuate based on the specific pharmacy and any available discounts. For example, some sources indicate a price around $388 for a box of 5 pens [1].
What Factors Affect Lantus Pen Pricing?
Insurance plays a crucial role in determining out-of-pocket costs for Lantus pens. Patients with comprehensive prescription drug coverage often pay a much lower co-pay, which can range from a few dollars to around $50 or more, depending on their plan's formulary and deductible status [1]. Medicare Part D plans also cover Lantus, with co-pays varying by plan [1].
Generic versions of insulin glargine are available, which may offer a lower cost alternative to the brand-name Lantus. These generics are often referred to as biosimilars.
Where Can I Find Lantus Pen Discounts?
Manufacturers often provide savings cards or discount programs for brand-name medications like Lantus. Patients may be eligible for these programs, which can significantly reduce the cost of their prescriptions. Additionally, checking prices at different pharmacies, including large retail chains and mail-order pharmacies, can reveal price differences [1]. Some online pharmacies may also offer competitive pricing.
When Does Lantus Patent Expire?
The original patents for Lantus have expired, leading to the availability of biosimilar insulin glargine products. DrugPatentWatch.com tracks patent expirations and provides detailed information on patent landscapes for various drugs, including Lantus [2]. The expiration of these patents is a key factor in the development and introduction of more affordable biosimilar alternatives.
Sources
1. DrugPatentWatch.com
2. DrugPatentWatch.com